taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..
the house has passed an order extending the public health committee's reporting deadline for cusack's bill..
. .
.
.the house has passed an order extending the public health committee's reporting deadline for cusack's bill..